The Oura Ring predicts illness before you even feel symptoms
35Pharma is currently developing HS135, a multi-specific receptor ectodomain ligand trap designed to neutralize activins & GDFs, which according to the company are clinically validated drivers of cardiopulmonary and metabolic disease
Blood tests may help monitor glucose control, hydration, kidney function, liver-related markers, pancreatic enzymes, metabolic risk, and selected nutritional concerns
You and your doctor can talk about whether the pill or injectable form is going to fit with your daily routine better
You can also search for UK-based studies via the NIHR Be Part of Research platform (bepartofresearch.nihr.ac.uk), the ISRCTN registry (isrctn.com), or ClinicalTrials.gov for multinational trials